Browse by Journal
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 3.
2025
| Reindl, Lisa Marie, Jalili, Lida, Bexte, Tobias, Harenkamp, Sabine, Thul, Sophia, Hehlgans, Stephanie, Wallenwein, Alina, Rothweiler, Florian, Cinatl, Jindrich, Michaelis, Martin, and others. (2025) Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy. Journal for ImmunoTherapy of Cancer, 13 . Article Number e011330. E-ISSN 2051-1426. (doi:10.1136/jitc-2024-011330) (KAR id:110534) |
|
2023
| Schlichtner, Stephanie, Yasinska, Inna M., Lall, Gurprit S., Berger, Steffen M., Ruggiero, Sabrina, Cholewa, Dietmar, Aliu, Nijas, Gibbs, Bernhard F., Fasler-Kan, Elizaveta, Sumbayev, Vadim V. and others. (2023) T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins. Journal for ImmunoTherapy of Cancer, 11 (1). Article Number e005714. E-ISSN 2051-1426. (doi:10.1136/jitc-2022-005714) (KAR id:99577) |
|
2021
| Filipski, Katharina, Scherer, Michael, Zeiner, Kim N, Bucher, Andreas, Kleemann, Johannes, Jurmeister, Philipp, Hartung, Tabea I, Meissner, Markus, Plate, Karl H, Fenton, Tim R., and others. (2021) DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma. Journal for ImmunoTherapy of Cancer, 9 (7). E-ISSN 2051-1426. (doi:10.1136/jitc-2020-002226) (KAR id:89373) |
|
